Jennifer Gershman, PharmD

home / authors / jennifer-gershman-pharmd

Articles

Oncology Overview: Taking a Closer Look at Axicabtagene Ciloleucel

Oncology Overview: Taking a Closer Look at Axicabtagene Ciloleucel

Jennifer Gershman, PharmD
July 26th 2021

Axicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.

Read More

Site Logo

Conjunctivitis 101

Jennifer Gershman, PharmD
May 3rd 2018

Conjunctivitis, commonly referred to as pink eye, involves inflammation of the outer layer of the eye and inside of the eyelid.

Read More

Latest Updated Articles

Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com
Published: August 19th 2024 | Updated: September 14th 2024
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors
Image Credit: © Zhanna - stock.adobe.com
Published: September 4th 2024 | Updated: September 14th 2024
Insights Into Immunotherapies For Adults With TP53-Mutated Acute Lymphoblastic Leukemia
Image Credit: © Gefo- stock.adobe.com
Published: September 7th 2024 | Updated: September 14th 2024
Expanding Treatment Horizons for Sickle Cell Disease: Barriers, Innovations, and Future Directions
X-ray of breast cancer -- Image credit: peterschreiber.media | stock.adobe.com
Published: August 28th 2024 | Updated: September 14th 2024
Pharmacists Enhance Care for Patients With HR+/HER2– Breast Cancer on CDK4/6 Inhibitor Therapy
Man receiving vaccine -- Image credit: New Africa | stock.adobe.com
Published: July 25th 2024 | Updated: September 14th 2024
Research Results Show Promise Toward Development of a Universal Influenza Vaccine
Proud mature woman smile after vaccination with bandage on arm. Beautiful smiling senior woman 70s after receiving the coronavirus vaccine. Elderly lady getting immunization via anti-viral vaccine - Image credit: Jelena Stanojkovic | stock.adobe.com
Published: August 15th 2024 | Updated: September 14th 2024
Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses